TIBER CREEK GROUP for ASSOCIATION FOR CLINICAL ONCOLOGY
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to H.R. 5371 - Continuing Appropriations and Extensions Act, 2026
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY KIRLIN | — |
| COREY MALMGREN | — |
| ANDREW MCKECHNIE | — |
| SEAN RICHARDSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.